← Back
$JANX All transactions

Janux Therapeutics, Inc.

A

$ Value

$0

Shares

3,750

Price

$0

Filed

Jun 13

Insider

Name

Hernday Natasha

Title

CIK

0001780547

Roles

Director

Transaction Details

Transaction Date

2025-06-11

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,731

Footnotes

Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date. | The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.

Filing Info

Accession No.

0001415889-25-017313

Form Type

4

Issuer CIK

0001817713

Hernday Natasha's History

Date Ticker Type Value
2025-06-11 JANX A $0
2025-06-11 JANX A $0
2025-05-21 XOMA A $0

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02